Suchergebnisse - "Lancet, Jeffrey E"

PubPharm (230)

1

Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML

enthalten in: Annals of hematology | 2024

von Jain, A. | Gesiotto, Q. | Ball, S. | +10

2

Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Ionescu, F. | David, J. | Ravichandran, A. | +15

3

Patterns of lower risk myelodysplastic syndrome progression : factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia

enthalten in: Haematologica | 2024

von Jain, A. | Ball, S. | Aguirre, L. | +10

4

Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia

enthalten in: American journal of hematology | 2023

von Patel, P. | Ball, S. | Jain, A. | +11

CommentOn: Am J Hematol. 2023 Mar;98(3):E53-E56. - PMID 36565294

5

Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Jain, A. | Ball, S. | Aguirre, L. | +8

6

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes

enthalten in: Blood advances | 2023

von Komrokji, R. | Aguirre, L. | Al Ali, N. | +7

7

Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes

enthalten in: Leukemia | 2023

von Aguirre, L. | Al Ali, N. | Sallman, D. | +9

8

Integrative molecular subtypes of acute myeloid leukemia

enthalten in: Blood cancer journal | 2023

von Mo, Q. | Yun, S. | Sallman, D. | +5

9

Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Shafer, D. | Kagan, A. | Rudek, M. | +9

10

Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Shafer, D. | Kagan, A. | Rudek, M. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]